Abstract: . . .  ankle brachial pressure ratio (ABR) in 3128 Type 2 DM patients           Incidence of new PVD in 1287 Type 2 patients under 70 years old with initially normal ABRs   0.17 %   3.7 %   7.3 %           Prevalence of peripheral neuropathy in 10121 Type 2 diabetic patients managed in 91 East Norfolk practices (data shown in 5 year age bands)           Numbers with peripheral vascular disease in the neuropathy population (n = 2392)   Estimated Ulcer incidence: 0.71 % RR 5.2 (2.1 8.4)           Admissions and bed occupancy with diabetes related foot ulceration by quarter between 1997 and 2002 at NNUH   *   *   Mean (SD) ; * p < 0.05           Integrated screening for diabetes complications                . . .
. . .         Audit /IT support : needed for end point analysis        Practice based vs population based diabetes care                  Conclusions and future developments         Administratively and financially low impact and could be funded through GMS contract .       Population with Type 2 DM highly characterised for macrovascular and microvascular complications, with identification of highest risk patients for further intervention (cf STDED)       Disengagement of front line staff from process in annual review   Epidemiology of PVD / neuropathy and CVD treatment   Care pathways   Diabetes care technicians           Norwich integrated screening programme     Grace Dole Crystel Jenkins Maggie Flatman  . . .
. . .  ratio (ABR) in 3128 Type 2 DM patients           Incidence of new PVD in 1287 Type 2 patients under 70 years old with initially normal ABRs   0.17 %   3.7 %   7.3 %           Prevalence of peripheral neuropathy in 10121 Type 2 diabetic patients managed in 91 East Norfolk practices (data shown in 5 year age bands)           Numbers with peripheral vascular disease in the neuropathy population (n = 2392)   Estimated Ulcer incidence: 0.71 % RR 5.2 (2.1 8.4)           Admissions and bed occupancy with diabetes related foot ulceration by quarter between 1997 and 2002 at NNUH   *   *   Mean (SD) ; * p < 0.05           Integrated screening for diabetes complications                . . .
--3000,3,500,3319,18714